Prange Karen

Director at ATRC; Director at ViewRay, Inc.; SVP&Pres, Uro & Pelvic Health at BSX

Sold, on record
$1.5M
Dollars the filings state
Form 4 sales
11
Latest Aug 5, 2026
Form 144 notices
4
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • ATRCAtriCure, Inc.Director
  • ViewRay, Inc.Director
  • BSXBOSTON SCIENTIFIC CORPSVP&Pres, Uro & Pelvic Health

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ATRCNo plan
    Jun 8, 2023 2023

    Sold 713 shares at $47.89 ($34k)

    Prange Karen, Director

    No 10b5-1 planSold 4.2% of holdings ($807k position)16,140 shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 144 notice ViewRay, Inc.Notice
    Jul 19, 2023 +41 days

    Filed to sell 91,866 shares ($7k)

    Prange Karen, Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 144 notice ViewRay, Inc.Notice
    Jul 21, 2023 +2 days

    Filed to sell 37,600 shares ($2k)

    Prange Karen, Director

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale ViewRay, Inc.Unusual
    Jul 21, 2023 same day

    Sold 129,466 shares at $0.0713 ($9k)

    Prange Karen, Director

    No 10b5-1 planSold 93.6% of holdings ($10k position)8,799 shares leftFirst sale on recordFollows a Form 144Filing

  5. 5 Form 144 notice ATRCNotice
    Mar 5, 2025 +593 days

    Filed to sell 6,100 shares ($232k)

    Prange Karen, Director

    No 10b5-1 planFiling

  6. 6 Form 4 sale ATRCUnusual
    Mar 5, 2025 same day

    Sold 6,100 shares at $38.12 ($233k)

    Prange Karen, Director

    No 10b5-1 planSold 25.5% of holdings ($912k position)17,828 shares leftFollows a Form 144Filing

  7. 7 Form 4 sale ATRCNo plan
    May 20, 2026 +441 days

    Sold 3,000 shares at $28.65 ($86k)

    Prange Karen, Director

    No 10b5-1 planSold 10.2% of holdings ($842k position)26,373 shares leftFiling

  8. 8 Form 4 sale ATRCNo plan
    Aug 5, 2026 +77 days

    Sold 3,564 shares at $38.80 ($138k)

    Prange Karen, Director

    No 10b5-1 planSold 13.5% of holdings ($1M position)22,809 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Prange Karen
Source
Aug 5, 2026Aug 7, 2026ATRCDirectorForm 4 sale3,564$138k13.5%No planSEC
May 20, 2026May 22, 2026ATRCDirectorForm 4 sale3,000$86k10.2%No planSEC
Mar 5, 2025Mar 7, 2025ATRCDirectorForm 4 sale6,100$233k25.5%UnusualSEC
Mar 5, 2025Mar 5, 2025ATRCDirectorForm 144 notice6,100$232kNoticeSEC
Jul 21, 2023Jul 21, 2023ViewRay, Inc.DirectorForm 4 sale129,466$9k93.6%UnusualSEC
Jul 21, 2023Jul 21, 2023ViewRay, Inc.DirectorForm 144 notice37,600$2kNoticeSEC
Jul 19, 2023Jul 19, 2023ViewRay, Inc.DirectorForm 144 notice91,866$7kNoticeSEC
Jun 8, 2023Jun 12, 2023ATRCDirectorForm 4 sale713$34k4.2%No planSEC
Jun 8, 2023Jun 8, 2023ATRCDirectorForm 144 notice713$34kNoticeSEC
Mar 8, 2016Mar 8, 2016BSXSVP&Pres, Uro & Pelvic HealthForm 4 sale14,747$255k27.8%UnusualSEC
Feb 8, 2016Feb 9, 2016BSXSVP&Pres, Uro & Pelvic HealthForm 4 sale6,216$100k20.8%Plan not statedSEC
Jul 7, 2015Jul 7, 2015BSXSVP&Pres, Uro & Women's HealthForm 4 sale17,456$308k50.0%UnusualSEC
Mar 3, 2015Mar 4, 2015BSXSVP&Pres, Uro & Women's HealthForm 4 sale2,492$42k12.5%Plan not statedSEC
Feb 27, 2015Mar 2, 2015BSXSVP&Pres, Uro & Women's HealthForm 4 sale1,307$22k7.0%Plan not statedSEC
Dec 10, 2014Dec 10, 2014BSXSVP&Pres, Uro & Women's HealthForm 4 sale19,753$250k53.1%UnusualSEC